1207 related articles for article (PubMed ID: 22366769)
1. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
[TBL] [Abstract][Full Text] [Related]
2. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
[TBL] [Abstract][Full Text] [Related]
3. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
[TBL] [Abstract][Full Text] [Related]
4. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of cognitive decline in different types of dementia.
Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
7. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
8. Early-versus late-onset Alzheimer's disease: more than age alone.
Koedam EL; Lauffer V; van der Vlies AE; van der Flier WM; Scheltens P; Pijnenburg YA
J Alzheimers Dis; 2010; 19(4):1401-8. PubMed ID: 20061618
[TBL] [Abstract][Full Text] [Related]
9. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline.
Vliet EC; Manly J; Tang MX; Marder K; Bell K; Stern Y
J Int Neuropsychol Soc; 2003 Jul; 9(5):720-32. PubMed ID: 12901778
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
11. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
Giovagnoli AR; Erbetta A; Reati F; Bugiani O
Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
13. Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia.
Stopford CL; Thompson JC; Neary D; Richardson AM; Snowden JS
Cortex; 2012 Apr; 48(4):429-46. PubMed ID: 21237452
[TBL] [Abstract][Full Text] [Related]
14. The computerized self test (CST): an interactive, internet accessible cognitive screening test for dementia.
Dougherty JH; Cannon RL; Nicholas CR; Hall L; Hare F; Carr E; Dougherty A; Janowitz J; Arunthamakun J
J Alzheimers Dis; 2010; 20(1):185-95. PubMed ID: 20164591
[TBL] [Abstract][Full Text] [Related]
15. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
16. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
[TBL] [Abstract][Full Text] [Related]
18. Impact of executive dysfunction on verbal memory performance in patients with Alzheimer's disease.
Gleichgerrcht E; Torralva T; Martinez D; Roca M; Manes F
J Alzheimers Dis; 2011; 23(1):79-85. PubMed ID: 20930305
[TBL] [Abstract][Full Text] [Related]
19. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
20. Can impairment in memory, language and executive functions predict neuropsychiatric symptoms in Alzheimer's disease (AD)? Findings from a cross-sectional study.
García-Alberca JM; Lara JP; Berthier ML; Cruz B; Barbancho MÁ; Green C; González-Barón S
Arch Gerontol Geriatr; 2011; 52(3):264-9. PubMed ID: 20570375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
